Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TETRALOGIC PHARMACEUTICALS CORP | 330,714 | reported | 26 Mar 2015 | tx 11+894,368 |
| Ampio Pharmaceuticals, Inc. | 146,858 | reported | 09 Jun 2023 | tx 7+371,858 |
| BIOSPECIFICS TECHNOLOGIES CORP | 85,000 | reported | 23 Oct 2019 | tx 1+85,000 |
| Benitec Biopharma Inc. | 35,000 | reported | 01 Dec 2025 | tx 12+411,666−155,439 |
| STEMLINE THERAPEUTICS INC | 24,000 | reported | 23 Jun 2015 | tx 5+74,500 |
| COMBINATORX, INC | 9,000 | reported | 05 Jun 2015 | tx 2+22,259 |
| Alaunos Therapeutics, Inc. | 4,167 | reported | 04 Mar 2021 | tx 3+181,607 |
| ENCYSIVE PHARMACEUTICALS INC | 0 | reported | 01 Apr 2008 | tx 8+27,636−11,253 |
| CEPHALON INC | 0 | reported | 14 Oct 2011 | tx 94+562,823−958,170 |
| Amneal Pharmaceuticals, Inc. | 0 | reported | 07 May 2026 | tx 31+764,218−587,920 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2026 | EXERCISE | Amneal Pharmaceuticals, Inc. | 34,819 | — | |
| 07 May 2026 | EXERCISE | Amneal Pharmaceuticals, Inc. | 34,819 | 0.00 USD | deriv |
| 06 May 2026 | GRANT_AWARD | Amneal Pharmaceuticals, Inc. | 19,824 | 0.00 USD | deriv |
| 01 Dec 2025 | GRANT_AWARD | Benitec Biopharma Inc. | 35,000 | 0.00 USD | deriv |
| 05 May 2025 | EXERCISE | Amneal Pharmaceuticals, Inc. | 40,258 | — | |
| 05 May 2025 | EXERCISE | Amneal Pharmaceuticals, Inc. | 40,258 | 0.00 USD | deriv |
| 06 May 2025 | GRANT_AWARD | Amneal Pharmaceuticals, Inc. | 34,819 | 0.00 USD | deriv |
| 12 Mar 2025 | GIFT | Benitec Biopharma Inc. | 103,626 | 0.00 USD | |
| 12 Mar 2025 | GIFT | Benitec Biopharma Inc. | 103,626 | 0.00 USD | |
| 10 Mar 2025 | GIFT | Amneal Pharmaceuticals, Inc. | 262,072 | 0.00 USD | |
| 27 Feb 2025 | EXERCISE | Benitec Biopharma Inc. | 51,813 | 3.86 USD | |
| 27 Feb 2025 | EXERCISE | Benitec Biopharma Inc. | 51,813 | 0.00 USD | deriv |
| 09 Dec 2024 | GRANT_AWARD | Benitec Biopharma Inc. | 35,000 | 0.00 USD | deriv |
| 10 May 2024 | EXERCISE | Amneal Pharmaceuticals, Inc. | 76,453 | — | |
| 10 May 2024 | EXERCISE | Amneal Pharmaceuticals, Inc. | 76,453 | 0.00 USD | deriv |
| 02 May 2024 | GRANT_AWARD | Amneal Pharmaceuticals, Inc. | 40,258 | 0.00 USD | deriv |
| 06 Dec 2023 | GRANT_AWARD | Benitec Biopharma Inc. | 35,000 | 0.00 USD | deriv |
| 11 Aug 2023 | PURCHASE | Benitec Biopharma Inc. | 51,813 | — | |
| 11 Aug 2023 | PURCHASE | Benitec Biopharma Inc. | 51,813 | — | deriv |
| 09 Jun 2023 | PURCHASE | Ampio Pharmaceuticals, Inc. | 21,858 | 0.29 USD | |
| 08 Jun 2023 | PURCHASE | Ampio Pharmaceuticals, Inc. | 25,000 | 0.30 USD | |
| 16 May 2023 | PURCHASE | Ampio Pharmaceuticals, Inc. | 32,534 | 0.27 USD | |
| 12 May 2023 | PURCHASE | Ampio Pharmaceuticals, Inc. | 23,440 | 0.24 USD | first after silence |
| 15 May 2023 | PURCHASE | Ampio Pharmaceuticals, Inc. | 44,026 | 0.25 USD | |
| 10 May 2023 | EXERCISE | Amneal Pharmaceuticals, Inc. | 80,128 | — |
1 purchase reported after at least 12 months of silence — most recent on 12 May 2023.